Fed Circuit resuscitates heart monitoring patent
20-04-2020
Fed Circuit won’t revisit Sanofi’s PTAB appeal despite Arthrex
30-01-2020
Ken Wolter / Shutterstock.com
The US Court of Appeals for the Federal Circuit granted the owner of an artificial heart valve patent a remand under Arthrex, but shot down the company’s attempt to escape an inter partes review (IPR) by citing a conflict.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Federal Circuit, St Jude Medical, Abbott, Snyders Heart Valve, IPR, Andrei Iancu, PTAB, USPTO, Arthrex, medical devices, heart valve, patents
